@Novartis Acquired $EYCT$24/Sh 2.1B
Lutetium-177 currently phase 3 

$ATNM current price .35 100M MC
1)gene therapy)P2 HIV readout 4qtr
2)Adoptive Cell Therapy (T-cells) p1
3)BMT conditioning P3 readout 4qtr   
4)AWE Technology Antibodies. P2
$bmy $mrk $nvs $lly $pfe $biib $vrtx